Technicals Stability Returns

Stock Analysis of Aurobindo Pharma , Birds-Eye-view
Technical Stability Returns Stock Strength Index
About Strength Screener
1D   1W   2W   1M   3M   1Y   2Y   5Y   
1W to 10Y Highs / Lows of AUROPHARMA
One Week503.0466.0
Two Weeks503.0444.75
One Month503.0444.75
Three Months503.0397.2
Six Months569.45397.2
One Year727.95397.2
Two Year1063.9397.2
Five Year1063.9288.85
Ten Year1063.963.575
Key Moving Average
5 Days 481.52    484.69   
10 Days 471.61    476.70   
15 Days 467.73    472.40   
20 Days 466.64    469.32   
50 Days 452.52    461.36   
100 Days 459.11    469.68   
200 Days 498.81    506.12   
Detailed MA Analysis of AUROPHARMA ...
Key Technical Indicators
MACD 8.31   
RSI 70.96   
RSI (Smooth) 69.59   
ADX 26.18   
Chaikin Money Flow 0.054   
Williams %R -4.38   
PSAR 454.39   
Super Trend 451.16   
Awesome Osc 16.69   
Detailed Tech Analysis AUROPHARMA ...
Financial Data Highlights
Market Cap29323.32 Cr
Enterprise Value27506.08 Cr
Book Value/ Share419.35
Revenue TTM24191.79
Gross Profit TTM13005.61
Revenue /Share TTM412.90
Consensus Target953.00
Key Financial Highlights AUROPHARMA ...
Financial Ratios of AUROPHARMA
Earning / Share45.19
Div Yield1.90
Trailing PE14.67
Forward PE8.36
Key Financial Ratios of AUROPHARMA ...
Key Profit & Loss Data
Net Inc 2648.15 50.36 %
Ops Income3132.28 30.03 %
Revenue23455.49 5.32 %
Ops Expense20243.88 1.59 %
PBT3403.99 53.99 %
Gross Profit13315.21 9.15 %
Div Paid-263.70 12.54 %
Closing Price500.55
Premium/Discount 0.100
Price Change 14.25
Change % 2.93
Future OI8187.00 K
OI Change % -25.75
Future Contracts8418.00
Contracts Change 133.57
Lot Size1000
Put / Call Options
Call Max Traded Strike Price500.00
Call Max Traded SP Contracts10815
Call Option Open Interest4385.00 K
Call Option OI Chg % -22.11
Put Max Traded Strike Price490.00
Put Max Traded SP Contracts3009
Put Option Open Interest4607.00 K
Put Option OI Chg % 31.48
Option Chain With Impled Vol & Greeks ...
Put Call Ratio - 29/03/2023
Put Open Interest4607.00 K
Call Open Interest4385.00 K
PCR Open Interest1.05
PCR OI ReadingStrong Bearish
Put Contracts Traded13544.00
Call Contracts Traded27748.00
PCR Volume0.488
PCR Vol ReadingBullish
Put Call Ratio AUROPHARMA ...
Price Range (PR) /Volatility
PeriodAvg PR Range %
LBD PR18.003.60
Week PR37.007.39
Month PR58.2511.64
5 Day Period14.473.05
10 Day Period16.093.46
5 Week Period28.566.34
3 Months Period67.3316.29
Price Range /Volatility AUROPHARMA ...
Highlights & Chart Patterns of Aurobindo Pharma Ltd.
Rising Price with Rising volume
Price rise supported with good volume.
Bullish Continuation Heikin Ashi Pattern formed
Long Term Higher High and Higher Lows , Top Points :500.45/24-Mar-23 00:00 479.9/16-Feb-23 00:00 , Bottom Points : 448.65/13-Mar-23 00:00 404.2/03-Feb-23 00:00
Medium Term Higher High and Higher Lows , Top Points :500.45/24-Mar-23 00:00 479.9/16-Feb-23 00:00 450.0/10-Jan-23 00:00 , Bottom Points : 448.65/13-Mar-23 00:00 404.2/03-Feb-23 00:00
Short Term Higher High and Higher Lows , Top Points :500.45/24-Mar-23 00:00 479.9/16-Feb-23 00:00 445.85/23-Jan-23 00:00 , Bottom Points : 448.65/13-Mar-23 00:00 404.2/03-Feb-23 00:00
Positive Breakout.

Share Price History of Aurobindo Pharma Ltd.

Date Open High Low Close Volume
24-Mar-23 486.00 503.00 485.00 500.45 4123 K
23-Mar-23 479.00 488.00 475.75 486.15 2085 K
22-Mar-23 469.00 480.25 466.00 478.75 1406 K
21-Mar-23 476.90 479.60 466.20 467.95 1057 K
20-Mar-23 476.40 481.45 467.35 474.30 3067 K
17-Mar-23 476.90 494.10 470.85 477.80 4731 K
16-Mar-23 458.30 477.00 458.00 473.25 3721 K
15-Mar-23 453.05 470.50 453.00 458.35 1812 K
14-Mar-23 449.05 460.15 447.05 450.45 1766 K
13-Mar-23 452.00 455.65 444.75 448.65 1433 K
About Aurobindo Pharma Limited
Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, and over-the-counter drugs, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In addition, the company develops and manufactures peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries. Further, it is developing biosimilar, inhalers, transdermal patches, vaccines, topicals, and depot injections. The company also exports its products. It serves multinational companies. The company has an agreement with COVAXX to develop and commercialize COVID-19 Vaccine for India and UNICEF. Aurobindo Pharma Limited was incorporated in 1986 and is headquartered in Hyderabad, India.
Steps To Customise this view
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide

About TSR TECH Strength / Valuation / Growth

TSR Tech Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is calculate from 5Mins Ticck to One Month Tick

TSR Growth analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access Growth Potential

TSR Value analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access its value

This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.